| Shukra Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
| 
 | 
 | 
 | 
| 
 | 
 | 
 | 
| 
 | 
 | 
 | 
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | 
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.06 | 0.10 | 0.20 | 0.41 | 0.57 | 
| Long Term Debt-Equity Ratio | 0.05 | 0.08 | 0.17 | 0.40 | 0.57 | 
| Current Ratio | 3.19 | 1.73 | 1.12 | 1.23 | 1.50 | 
| Fixed Assets | 0.77 | 1.85 | 1.58 | 0.60 | 0.34 | 
| Inventory | 5.32 | 27.27 | 16.55 | 7.28 | 7.30 | 
| Debtors | 1.96 | 2.73 | 3.13 | 2.39 | 1.27 | 
| Interest Cover Ratio | 23.61 | 69.59 | 16.89 | 4.52 | 11.00 | 
| PBIDTM (%) | 51.95 | 29.80 | 11.15 | 14.49 | 16.07 | 
| PBITM (%) | 42.74 | 27.05 | 8.02 | 6.39 | 2.95 | 
| PBDTM (%) | 50.14 | 29.41 | 10.67 | 13.08 | 15.80 | 
| CPM (%) | 38.60 | 27.61 | 10.62 | 11.76 | 14.38 | 
| APATM (%) | 29.40 | 24.86 | 7.50 | 3.66 | 1.25 | 
| ROCE (%) | 21.76 | 44.16 | 18.84 | 5.81 | 1.35 | 
| RONW (%) | 15.90 | 44.71 | 21.18 | 4.69 | 0.90 |